Drug Profile
Azasetron
Alternative Names: Nazasetron; Serotone; Y 25130Latest Information Update: 01 Oct 2007
Price :
$50
*
At a glance
- Originator Mitsubishi Pharma Corporation
- Developer Japan Tobacco; Mitsubishi Pharma Corporation; Mitsubishi Tanabe Pharma Corporation; Taiho Pharmaceutical; Torii Pharmaceutical; University of California at San Francisco
- Class Antiemetics; Antineoplastics; Heterocyclic bicyclo compounds; Oxazines
- Mechanism of Action Serotonin 3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Nausea and vomiting
- Discontinued Cocaine-related disorders; Gastrointestinal disorders
Most Recent Events
- 01 Oct 2007 Mitsubishi Pharma Corporation has merged with Tanabe Seiyaku to form Mitsubishi Tanabe Pharma Corporation
- 08 May 2007 Discontinued - Preclinical for Cocaine abuse in USA (unspecified route)
- 16 May 2002 Discontinued - Phase-II for Gastrointestinal disorders in Japan (PO)